Sestrin2 upregulation was shown to accelerate autophagic Keap1 degradation and improve Nrf2-mediated antioxidant response in a rat model of diabetic nephropathy and murine podocyte cell line exposed to high glucose concentration [100]. The gene discussed is KEAP1; the disease is diabetic kidney disease.